• About
  • Contact
  • Advertise
  • Privacy Policy
  • Terms Of Use
Monday, June 23, 2025
No Result
View All Result
Converseer
  • Home
  • News
    • General News
    • Education
    • Business
    • Security
    • Entertainment
    • Lifestyle
    • Tourism
  • Politics
  • Metro
  • Jobs
  • Sports
  • Health
  • Tech
  • More
    • Science & Nature
    • Agriculture
    • Opinion
    • Feature
    • Fact Check
    • History
    • Profile & Biography
    • Special Reports
  • Home
  • News
    • General News
    • Education
    • Business
    • Security
    • Entertainment
    • Lifestyle
    • Tourism
  • Politics
  • Metro
  • Jobs
  • Sports
  • Health
  • Tech
  • More
    • Science & Nature
    • Agriculture
    • Opinion
    • Feature
    • Fact Check
    • History
    • Profile & Biography
    • Special Reports
No Result
View All Result
Converseer
No Result
View All Result
Home Health

Safety concerns: AstraZeneca withdraws COVID-19 vaccine from circulation

by Editorial Team
8 May 2024
in Health
Safety concerns: AstraZeneca withdraws COVID-19 vaccine from circulation

Pharmaceutical giant, AstraZeneca has formally asked the European Medicines Agency to withdraw its COVID-19 vaccine authorisation.

In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorisation holder.”

According to Africanews, the vaccine, initially approved in January 2021, faced safety concerns over rare blood clots, prompting various countries to halt its use temporarily.

While the EU regulator determined that the overall risk was low, doubts lingered. Additionally, limited data on its effectiveness in older adults led to initial restrictions.

Billions of doses of the AstraZeneca vaccine were distributed to poorer countries through a U.N.-coordinated programme, as it was cheaper and easier to produce and distribute.

READ ALSO: Over 17.5m PWDs require basic education – Lalu

However, studies later suggested that the pricier messenger RNA vaccines made by Pfizer-BioNTech and Moderna provided better protection against COVID-19 and its many variants, and most countries switched to those shots.

The U.K.’s national coronavirus immunisation programme in 2021 heavily relied on AstraZeneca’s vaccine, which was largely developed by scientists at Oxford University with significant financial government support.

But even Britain later resorted to buying the mRNA vaccines for its COVID booster vaccination programmes and the AstraZeneca vaccine is now rarely used globally.

Tags: COVID-19 NewsWorld News
ShareSendTweetShare

Related News

World Bank grants $40m to Nigeria to boost health coverage for vulnerable groups

World Bank grants $40m to Nigeria to boost health coverage for vulnerable groups

17 June 2025
Bishop Otu flags off 7th free medical outreach in Calabar

Bishop Otu flags off 7th free medical outreach in Calabar

17 June 2025
Germany confirms first case of African Swine Fever (ASF)

Germany confirms first case of African Swine Fever (ASF)

15 June 2025
Cases of Long COVID still growing in Germany

New coronavirus variant seen in Germany – WHO

12 June 2025

Latest News

Tinubu calls on Sahel States to rejoin ECOWAS

Sierra Leone’s Maada Bio emerges new ECOWAS chairman

Iran fires missiles at US Airbase in Qatar

Dr Godwin Agbor receives Excellent Service to Humanity award

Malawian-born Chioma Okafor commits international football career to Nigeria

Iran’s FM Araqchi to hold talks with Putin

About Us

Converseer is an online newspaper that delivers impartial, comprehensive news coverage on politics, business, and education, among other topics. Our goal is to bridge the information gap and promote progress across various sectors of society.

Social Media

  • Facebook
  • WhatsApp
  • X (Twitter)
  • YouTube

Coverage

  • Africa
  • Americas
  • Asia
  • Europe
  • Middle East

Topics

  • Special Reports
  • Fact Check
  • Feature
  • Opinion
  • History
  • About
  • Contact
  • Advertise
  • Privacy Policy
  • Terms Of Use

© 2025 Converseer - All Rights Reserved. Paradise Media Venture.

No Result
View All Result
  • Home
  • News
    • General News
    • Education
    • Business
    • Security
    • Entertainment
    • Lifestyle
    • Tourism
  • Politics
  • Metro
  • Jobs
  • Sports
  • Health
  • Tech
  • More
    • Science & Nature
    • Agriculture
    • Opinion
    • Feature
    • Fact Check
    • History
    • Profile & Biography
    • Special Reports

© 2025 Converseer - All Rights Reserved. Paradise Media Venture.